Tebotelimab Plus Niraparib in Previously Treated Locally Advanced or Metastatic Solid Tumors: A Phase 1b Dose Escalation and Expansion Study.
Cancer(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined